Immune Heterogeneity in Small-Cell Lung Cancer and Vulnerability to Immune Checkpoint Blockade

Investigators conducted transcriptomic analyses and non-negative matrix factorization on 271 pre-treatment patient tumor samples from IMpower133 and identified four subsets with general concordance to previously reported small-cell lung cancer subtypes.